HOME >> BIOLOGY >> NEWS
Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation

Charlestown, MA, July 14, 2003 -- In this issue of the journal Virology, (Vol. 312, Number 2, August 1, 2003) researchers from Immerge BioTherapeutics, Inc., (a BioTransplant Incorporated (Nasdaq:BTRN) /Novartis Pharma AG (NYSE:NYS) joint venture company) announced that recombination between porcine and human endogenous retrovirus was not detected when using sensitive laboratory tests, leading the authors to conclude that the creation of a new virus from the two was highly unlikely. Although the risk of recombination is purely theoretical, it has been of concern to xenotransplant researchers. This study represents an important finding and the most recent advance in the Immerge safety program, which is dedicated to addressing potential issues in the safety risk of pig-to-human xenotransplantation.

"We utilized a laboratory model to simulate PERV (porcine endogenous retrovirus) transmission by infecting human cells with the virus," said Dr Clive Patience, Director of the Safety Program at Immerge. "We found that human retrovirus elements were not detectable in the PERV particles released from the infected human cells. These results are encouraging, as we used very sensitive assays that can detect 1 out of 50,000 to 1 out of 10 million elements. Therefore, if human cells were ever to become infected by PERV, the likelihood of porcine and human viruses recombining to form a novel infectious virus is extremely remote."

PERV is a natural virus in pigs, but does not cause any disease in these animals. In certain laboratory conditions PERV can infect cells from other species, including some human cells. However, there are no indications that PERV infection has occurred in living individuals, including humans that have been treated with pig tissues or those that are in regular direct contact with living pig cells or tissues.

"The risk of cross-species spread of PERV should be balanced by the potential efficacy of the transplanted tissue," comme
'"/>

Contact: Susan Hayes
shayesconsult@earthlink.net
212-533-4472
S. Hayes Consulting
14-Jul-2003


Page: 1 2

Related biology news :

1. Immerge reports PERVs most infectious to human cells not part of germ-line DNA of mini-swine
2. Immerge BioTherapeutics announces identification of PERV receptor
3. Immerge biotherapeutics identifies miniature swine that do not transmit pig retrovirus to humans
4. Secretary of Energy announces seven E.O. Lawrence Award Winners
5. Popular Science announces Third Annual Brilliant 10
6. The American Phytopathological Society announces 2004 awards
7. NSF announces six FIBR awards to tackle some of biologys most challenging questions
8. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
9. JGI announces community sequencing program portfolio
10. APS announces the winners of its 2004 postdoctoral fellowship in physiological genomics
11. National Corn Growers Association announces valuable maize genome data now available to scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: